Biologics Regulatory Spine Top Stories Bone Solutions Receives 510(k) Clearance for Expanded Indications of Use for Mg OSTEOCRETE in Intervertebral Body Fusion Procedures byJosh SandbergFebruary 13, 2024
Biologics Regulatory Top Stories Mg OSTEOINJECT from Bone Solutions Receives 510(k) Clearance for Expanded Indications byJosh SandbergJuly 13, 2022
Spine Top Stories Bone Solutions Inc. Receives FDA Clearance for Mg OSTEOREVIVE Spine Magnesium-Based Bone Void Filler byJosh SandbergFebruary 2, 2022
Biologics Spine Top Stories Bone Solutions Launches Mg OSTEOINJECT Injectable Magnesium-Based Bone Void Filler byJosh SandbergJanuary 25, 2022
Biologics Bone Solutions Inc. Successfully Surpasses 1,000 Implanted Cases with OsteoCrete® Magnesium-Based Bone Void Filler byJosh SandbergFebruary 25, 2020
Biologics Bone Solutions Inc. partners with Onkos Surgical for private label licensing agreement utilizing the OsteoCrete® platform technology byJosh SandbergAugust 28, 2019
Biologics Bone Solutions Inc. has successfully completed 250 cases with OsteoCrete® Magnesium-Based Bone Void Filler byJosh SandbergOctober 2, 2018
Biologics Top Stories Bone Solutions Inc. Launches OsteoCrete® Magnesium-Based Bone Void Filler byJosh SandbergSeptember 19, 2017
Spine In a First for the Orthopedic Industry, Bone Solutions of Dallas (BSI) Has Received Formal Patent Approval for Its Groundbreaking Magnesium Based Resorbable Bio-Material byJosh SandbergSeptember 14, 2015
